Antidepressants and GLP-1s: delayed emptying, not a DIY mix-and-match

Two prescriptions, two clinicians, one medication list

People search “Ozempic and Zoloft” hoping for a green light. The honest version is: obesity and depression often coexist, both are treated with oral and injectable medicines, and GLP-1 labels mainly warn that delayed gastric emptying can change oral-drug absorption. They do not replace a psychiatrist’s plan.

This article is educational. It is not a direction to start a GLP-1, stop an antidepressant, or change a dose. If you have thoughts of suicide or self-harm, call 988 in the United States or use local emergency services. Do not wait for a weight-loss visit.

Delayed emptying is the main labeled interaction theme

Wegovy, Ozempic, Zepbound, and Mounjaro slow gastric emptying. Labels tell clinicians to consider extra monitoring for oral medicines that need careful levels. Weekly injectable semaglutide drug-interaction work has often shown little change for several oral probes, but that is not a blanket “all tablets are unaffected” statement. Oral semaglutide (SNAC) has more notable absorption findings.

Extended-release psychiatric medicines and medicines taken on an empty stomach for a reason may need a pharmacist review when a GLP-1 starts. Bring the actual bottles, not memory.

Mood, FDA’s review, and moving labels

After postmarketing reports, FDA publicly discussed suicidal thoughts or actions with certain GLP-1 receptor agonists. The January 2024 FDA update described a preliminary evaluation that did not find a causal association, while asking manufacturers and the public to keep reporting. Labels are living documents. Wegovy’s highlights note that a suicidal behavior and ideation warning was removed in January 2026. Always read the PI dated on your carton, not a screenshot from last year.

Weight reduction, GI misery, sleep change, and life stress can all move mood in either direction. New anhedonia, hopelessness, or agitation deserves a prompt mental-health contact even if a boxed warning is absent.

Do not stop the antidepressant to “simplify”

Internet threads sometimes blame SSRIs for weight and suggest stopping them when a GLP-1 starts. That is a relapse risk. Some antidepressants are associated with weight change; that is a reason to review options with a psychiatrist, not to cold-turkey a medicine that is keeping someone well.

If nausea makes swallowing pills hard, ask about timing with meals, alternative formulations, or a slower GLP-1 titration. Do not crush extended-release psychiatric tablets unless the label allows it.

• Keep one shared medication list for every clinician and pharmacist.
• Report mood changes at GLP-1 follow-up and at mental-health follow-up.
• Avoid alcohol binges; see the alcohol article.
• Never use a marketing form to describe suicide risk in free text meant for ads.

Older adults, pregnancy, and surgery

Older adults may be more sensitive to anticholinergic or sedating antidepressants plus dehydration from GLP-1 GI effects. See the older-adults article. Pregnancy and lactation add separate rules for both drug classes; see breastfeeding and postpartum articles.

Before surgery, anesthesia teams need both lists. Some antidepressants interact with certain pain or anesthesia medicines. GLP-1s add aspiration-risk planning. See the surgery article. Do not hold either class based on a packing list.

Frequently asked questions

Sources

1. [1] Wegovy (semaglutide) prescribing information. Novo Nordisk. Delayed gastric emptying and oral medications; recent major changes including removal of the suicidal behavior warning in January 2026.
2. [2] Zepbound (tirzepatide) prescribing information. Eli Lilly. Oral medication absorption, including oral contraceptives; gastrointestinal warnings.
3. [3] U.S. Food and Drug Administration. Drug Safety Communication: update on FDA's ongoing evaluation of reports of suicidal thoughts or actions in patients taking medicines approved for type 2 diabetes and obesity.
4. [4] Ozempic (semaglutide) prescribing information. Novo Nordisk. Drug interactions: oral medications and delayed gastric emptying.
5. [5] National Institute of Mental Health. Depression. Treatment should be supervised; do not stop antidepressants suddenly.